Adventitia contribution in vascular tone: Insights from adventitia-derived cells in a tissue-engineered human blood vessel

FASEB Journal

Volumn 20, Issue 8, 2006, Pages

  Laflamme, Karina ^a,b   Roberge, Charles J ^a,b   Grenier, Guillaume ^a,b   Rémy Zolghadri, Murielle ^a,b   Pouliot, Stéphanie ^a,b   Baker, Kathleen ^a,b   Labbé, Raymond ^a,b   D'Orléans Juste, Pédro ^c   Auger, François A ^a,b   Germain, Lucie ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Adventitia; Blood vessel; Contraction; Endothelin; Media

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; NITROPRUSSIDE SODIUM; ASPARTIC PROTEINASE; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN-CONVERTING ENZYME 1; MESSENGER RNA; METALLOPROTEINASE;

ADULT; ADVENTITIA; ARTICLE; BLOOD VESSEL TONE; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; BLOOD VESSEL; BLOOD VESSEL PROSTHESIS; CONNECTIVE TISSUE; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; VASODILATATION;

ASPARTIC ENDOPEPTIDASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; CONNECTIVE TISSUE; ENDOTHELINS; HUMANS; METALLOENDOPEPTIDASES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RNA, MESSENGER; TISSUE ENGINEERING; TUNICA MEDIA; VASOCONSTRICTION; VASODILATION;

EID: 33845609560     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-4702fje     Document Type: Article

References (41)

1. Rhodin, J. A. G. (1980) Architecture of the vessel wall. In Handbook of Physiology. Section 2: The Cardiovascular System. Volume II: Vascular Smooth Muscle. (Bohr, D.F., Somlyo, A.P., Sparks, H.V.Jr., eds) pp. 1-31, Am. Physiol. Soc., Bethesda, MD
2. Moncada, S., Palmer, and R. M., Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43, 109-142
3. Gonzalez, M. C., Arribas, S. M., Molero, F., and Fernandez-Alfonso, M. S. (2001) Effect of removal of adventitia on vascular smooth muscle contraction and relaxation. Am. J. Physiol. Heart Circ. Physiol. 280, 2876-2881
4. Arnal, J. F., Battle, T., Rasetti, C., Challah, M., Costerousse, O., Vicaut, E., Michel, J. B., and Alhenc-Gelas, F. (1994) ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am. J. Physiol. 267, 1777-1784
5. Battle, T., Arnal, J. F., Challah, M., and Michel, J. B. (1994) Selective isolation of rat aortic wall layers and their cell types in culture-application to converting enzyme activity measurement. Tissue Cell 26, 943-955
6. Kemler, M. A., Kolkman, W. F., Slootweg, P. J., and Kon, M. (1997) Adventitial stripping does not strip the adventitia. Plast. Reconstr. Surg. 99, 1626-1631
7. Lohman, R., Siemionow, M., Rockwell, W.B., and Lister, G. D. (1995) Acute adverse effects of blunt adventitial stripping. Ann. Plast. Surg. 35, 60-65
8. L'Heureux, N., Paquet, S., Labbe, R., Germain, L., and Auger, F. A. (1998) A completely biological tissue-engineered human blood vessel. FASEB J. 12, 47-56
9. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., and Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415
10. Haynes, W. G., and Webb, D. J. (1994) Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344, 852-854
11. Spratt, J. C., Goddard, J., Patel, N., Strachan, F. E., Rankin, A. J., and Webb, D. J. (2001) Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br. J. Pharmacol. 134, 648-654
12. Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., and Masaki, T. (1989) The human endothelin family three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U. S. A. 86, 2863-2867
13. Arai, H., Hori, S., Aramori, I., Ohkubo, H., and Nakanishi, S. (1990) Cloning and expression of cDNA encoding an endothelin receptor. Nature 348, 730-732
14. Grenier, G., Rémy-Zolghadri, M., Guignard, R., Bergeron, F., Labbé, R., Auger, F. A., and Germain, L. (2003) Isolation and culture of the three vascular cell types from a small vein biopsy sample. In Vitro Cell Dev. Biol. Anim. 39, 131-139
15. L'Heureux, N., Stoclet, J. C., Auger, F. A., Lagaud, G. J., Germain, L., and Andriantsitohaina, R. (2001) A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J. 15, 515-524
16. D'Orléans-Juste, P., Plante, M., Honoré, J. C., Carrier, E., and Labonté, J. (2003) Synthesis and degradation of endothelin-1. Can. J. Physiol. Pharmacol. 81, 503-510
17. Bates, J. N., Baker, M. T., Guerra, R. Jr., and Harrison, D. G. (1991) Nitric oxide generation from nitroprusside by vascular tissue. Biochem. Pharmacol. 42, S157-S165
18. Ergul, A., Shoemaker, K., Puett, D., and Tackett RL. (1998) Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. J. Pharmacol. Exp. Ther. 285, 511-517
19. White, D. G., Garratt, H., Mundin, J. W., Sumer, M. J., Vallance, P. J., and Watts, I. S. (1994) Human sapheous vein contains both endothelin ETA and ETB contractile receptors. Eur. J. Pharmacol. 257, 307-310
20. Bax, W. A., Bos, E., and Saxena, P. R. (1993) Heterogeneity of endothelin/sarafotoxin receptors mediating contraction of the human isolated saphenous vein. Eur. J. Pharmacol. 239, 267-268
21. Laflamme, K., Roberge, C. J., Labonte, J., Pouliot, S., D'Orleans-Juste, P., Auger, F. A., and Germain, L. (2005) Tissue-engineered human vascular media with a functional endothelin system. Circulation 111, 459-464
22. Scotland, R., Vallance, P., and Ahluwalia, A. (1999) On the regulation of tone in vasa vasorum. Cardiovasc Res 41, 237-245
23. Scotland, R. S., Vallance, P. J. T., and Ahluwalia, A. (1999) Endothelin alters the reactivity of vasa vasorum: mechanisms and implications for conduit vessel physiology and pathophysiology. Br. J. Pharmacol. 128, 1229-1234
24. Williams, J. K., Armstrong, M. L., and Heistad, D. D. (1988) Blood flow through new microvessels: factors that affect regrowth of vasa vasorum. Am. J. Physiol. 254, 126-132
25. Lancaster, J. R. Jr. (1997) A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1, 18-30
26. Olson, L. J., Knych, E. T. Jr., Herzig, T. C., and Drewett, J. G. (1997) Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension 29, 254-261
27. Miyauchi, T., and Masaki, T. (1999) Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol. 61, 391-415
28. McMahon, E. G., Palomo, M. A., Brown, M. A., Bertenshaw, S. R., and Carter, J. S. (1993) Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats. Am. J. Hypertens. 6, 667-673
29. De Lombaert, S., Ghai, R. D., Jeng, A. Y., Trapani, A. J., Webb, R. L. (1994) Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem. Biophys. Res. Commun. 204, 407-412
30. Jeng, A. Y., Mulder, P., Kwan, A. L., and Battistini, B. (2002) Nonpeptidic endothelin-converting enzyme inhibitors and their therapeutic applications. Can. J. Physiol. Pharmacol. 80, 440-449
31. Shimada, K., Matsushita, Y., Wakabayashi, K., Takahashi, M., Matsubara, A., Iijima, Y, and Tanzawa, K. (1995) Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem. Biophys. Res. Commun. 207, 807-812
32. Xu, D., Emoto, N., Giaid, A., Slaughter, C., Kaw, S., deWit, D., and Yanagisawa, M. (1994) ECE-1: a membrane bound metalloprotease that catalyzes the proteolytic activation of Big endothelin-1. Cell 78, 473-485
33. Schimidt, M., Kroger, B., Jacob, E., Seulberger, H., Subkowski, T., Otter, R., Meyer, T., Schmalzing, G., and Hillen, H. (1994) Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett. 356, 238-243
34. Korth, P., Bohle, R. M., Corvol, P., and Pinet, F. (1999) Cellular distribution of endothelin-converting enzyme-1 in human tissues. J. Histochem. Cytochem. 47, 447-462
35. Hachiya, A., Kobayashi, T., Takema, Y., and Imokawa, G. (2002) Biochemical characterization of endothelin-converting enzyme-1alpha in cultured skin-derived cells and its postulated role in the stimulation of melanogenesis in human epidermis. J. Biol. Chem. 277, 5395-5403
36. Schwartz, C. J., and Mitchell, J. R. A. (1962) Cellular infiltration of the human arterial adventitia associated with atheromatous plaques. Circulation 26, 73-78
37. Wilcox, J. N., and Scott, N. A. (1996) Potential role of the adventitia in arteritis and atherosclerosis. Int. J. Cardiol. 54, S21-S35
38. van der Loo, B. and Martin, J. F. (1997) The adventitia, endothelium and atherosclerosis. Int. J. Microcirc. Clin. Exp. 17, 280-288
39. Wang, H.D., Hope, S., Du, Y., Quinn, M.T., Cayatee, A., Pagano, P.J., and Cohen, R. A. (1999) Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension. 33, 1225-1232
40. Barra, J.A., Volant, A., Leroy, J.P., Braesco, J., Airiau, J., Boschat, J., Blanc, J.J., Penther, P. (1986) Constrictive perivenous mesh prosthesis for preservation of vein integrity. Experimental results and application for coronary bypass grafting. J. Thorac. Cardiovasc. Surg. 92, 330-336
41. Zurbrugg, H.R., Knollmann, F., Musci, M., Wied, M., Bauer, M., Chavez, T., Krukenberg, A., and Hetzer, R. (2000) The biocompound method in coronary artery bypass operations: surgical technique and 3-year patency. Ann. Thorac. Surg. 70, 1536-1540